IRCCS Giannina Gaslini
Genova, Genoa, Italy
Nicolino Ruperto, MD, MPH, works as Pediatric Rheumatologist at the Gaslini Children’s Hospital one of the biggest children’s hospital in Italy. He is Senior Scientist of the Paediatric Rheumatology International Trials Organisation (PRINTO at www.printo.it) in Genova, Italy.
Dr. Ruperto earned his medical degree from the University of Pavia in Pavia, Italy, with a specialization in pediatrics. He also has a specialization in pediatric rheumatology from the Children’s Hospital Medical Center in Cincinnati, Ohio. Dr. Ruperto earned his master of public health degree from Harvard School of Public Health in Boston, Massachusetts and his Executive Master in Health Management from the Bocconi University in Milan.
Dr. Ruperto is among the founders of the Paediatric Rheumatology International Trials Organisation (PRINTO at www.printo.it), where he has managed all collaborative international academic research projects conducted by the network with over 42,000 data collected from children with pediatric rheumatic diseases from over 300 centres in more than 60 countries. He was awarded the 2005 Gerolamo Gaslini Prize for Excellence in Research from the Gerolamo Gaslini Foundation and the 2022 Distinguished International Rheumatology Professional Award the American College of Rheumatology
Metrics: Over 400 manuscripts peer reviews on prestigious international journal: h-index May 2024 (Scopus 85; google scholar 97), citations (Scopus 22407; GS 38668).
18M45: How You Do Depends on Where You Live: JIA Outcomes Across the World
Monday, November 18, 2024
3:00 PM – 4:30 PM Eastern Time
Disclosure(s): AbbVie/Abbott: Consultant (Terminated, March 20, 2023); AclarisTx: Consultant (Ongoing); Amgen: Consultant (Ongoing); AstraZeneca(Medimmune: Consultant (Ongoing); Aurinia: Consultant (Ongoing); Boehringer Ingelheim: Consultant (Ongoing); Bristol Myers and Squibb: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Galapagos/AlfaSigma: Consultant (Ongoing); Guidepoint: Consultant (Ongoing); Idorsia: Consultant (Ongoing); Janssen: Consultant (Ongoing); Novartis: Consultant (Ongoing); Pfizer: Consultant (Ongoing); Roche Genentech: Consultant (Ongoing); Takeda: Consultant (Ongoing)